Was the COVID-19 recession pro-poor in the US, and if so, what was behind it?

被引:0
|
作者
Wang, Zuobao [1 ,3 ]
Lin, Tianrun [1 ]
Chen, Yao [2 ]
Xing, Xinyi [1 ]
机构
[1] Northeastern Univ, Sch Humanities & Law, Shenyang, Peoples R China
[2] Shenyang Urban Construct Univ, Sch Management, Shenyang 110167, Peoples R China
[3] Northeastern Univ, Sch Humanities & Law, 195 Chuangxin Rd, Shenyang 110169, Liaoning, Peoples R China
关键词
Pro-poor recession; COVID-19; poverty; inequality; US;
D O I
10.1080/13504851.2024.2308570
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper assesses whether the 2020 COVID-19 recession in the US was pro-poor and identifies the primary factors influencing the dynamics. The results show that during the COVID-19 recession of 2020, poverty reduction was predominantly driven by an increase in equivalent income in the US, accompanied by improved inequality. Public social benefits experienced a substantial rise, counteracting the decline in other income sources and contributing to improving the inequality.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] COVID-19 and the heart: what we have learnt so far
    Shaha, Kunal Bikram
    Manandhar, Dhiraj Narayan
    Cho, Jung Rae
    Adhikari, Ashok
    Bahadur, Man K. C.
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1152) : 655 - 666
  • [22] Facing COVID-19 challenges: What is so special in family businesses?
    Dettori, Angela
    Floris, Michela
    TQM JOURNAL, 2022, 34 (07) : 39 - 53
  • [23] COVID-19 and Anemia: What Do We Know So Far?
    Abu-Ismail, Luai
    Taha, Mohammad J. J.
    Abuawwad, Mohammad T.
    Al-Bustanji, Yaqeen
    Al-Shami, Khayry
    Nashwan, Abdulqadir
    Yassin, Mohamed
    HEMOGLOBIN, 2023, 47 (03) : 122 - 129
  • [24] COVID-19 and the Radiology Department: What We Know So Far
    Sanya Vermani
    Aditya Kaushal
    Jessica Kaushal
    SN Comprehensive Clinical Medicine, 2020, 2 (11) : 1998 - 2004
  • [25] COVID-19 and diabetes: What do we know so far?
    Gangadaran, Prakash
    Padinjarathil, Himabindu
    Rajendran, Shri Hari Subhashri
    Jogalekar, Manasi P.
    Hong, Chae Moon
    Aruchamy, Baladhandapani
    Rajendran, Uma Maheswari
    Gurunagarajan, Sridharan
    Krishnan, Anand
    Ramani, Prasanna
    Subramanian, Kavimani
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (15) : 1330 - 1334
  • [26] COVID-19 in Immunocompromised Hosts: What We Know So Far
    Fung, Monica
    Babik, Jennifer M.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 340 - 350
  • [27] COVID-19 and the liver: What do we know so far?
    Nasa, Prashant
    Alexander, George
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (05) : 522 - 532
  • [28] Obesity and COVID-19: what makes obese host so vulnerable?
    Mohammad, Sameer
    Aziz, Rafia
    Al Mahri, Saeed
    Malik, Shuja Shafi
    Haji, Esraa
    Khan, Altaf Husain
    Khatlani, Tanvir Saleem
    Bouchama, Abderrezak
    IMMUNITY & AGEING, 2021, 18 (01)
  • [29] COVID-19 and diabetes: What have we learned so far?
    Taher, Nida
    Huda, Mohammed S. B.
    Chowdhury, Tahseen A.
    CLINICAL MEDICINE, 2020, 20 (04) : E87 - E90
  • [30] Liver dysfunction and COVID-19: what we know so far
    Hachimi, Abdelhamid
    Ait-Errami, Adil
    el Hidan, Moulay Abdelmonaim
    Merzouki, Mohamed
    KUWAIT MEDICAL JOURNAL, 2023, 55 (04): : 279 - 291